The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/14836
StudyName: Eligibility Chronic Myeloproliferative Disorders NCT00069992
Date of export from the portal: 02.07.2020
Date of Upload / last change: 01.05.2016
License: Creative Commons BY 4.0

----

Description: 
Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML; ODM derived from: https://clinicaltrials.gov/show/NCT00069992
